All In Biotech

Free tool

FAERS Monitor: Lidocaine Hydrochloride 0.8% and Dextrose 5% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018461 or its brand name (Lidocaine Hydrochloride 0.8% and Dextrose 5% In Plastic Container, Lidocaine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

7,041

Serious

4,863

69% of reports

Hospitalization

2,546

Death reported

583

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • infusion site pain792
  • drug ineffective575
  • nausea517
  • infusion site erythema494
  • headache464
  • dyspnoea449
  • diarrhoea445
  • off label use430
  • fatigue390
  • pain374
  • infusion site swelling345
  • dizziness325
  • vomiting314
  • hypotension243
  • infusion site haemorrhage233

Reports by year received

View as table
YearReports
200435
200518
20069
20079
200828
200951
201050
201164
201285
201390
201457
2015166
2016121
2017139
2018171
2019168
2020199
2021324
2022593
2023990
20241,457
20251,368
2026849

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,118 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion site haemorrhageSignal233227.6199.648,646
infusion site painSignal792195.5182.7143,774
infusion site erythemaSignal494185.9170.285,374
infusion site swellingSignal345173.2155.855,696
hypotensionSignal2433.63.2462
dyspnoeaSignal4492.42.2364
headacheSignal4642.22.0316
diarrhoeaSignal4452.11.9249
vomiting3142.01.8158
nausea5172.01.8248
dizziness3251.91.8152
pain3741.81.6141
fatigue3901.51.466
off label use4301.51.366
drug ineffective5751.31.243

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.